Seven Eight Capital, LP Bio Techne Corp Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $533,118 - $622,887	8,080 New	8,080 $568,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $411,466 - $544,925	6,094 New	6,094 $414,000
Q2 2020 Aug 06, 2020	SELL	$185.43 - $279.56 $222,516 - $335,472	-1,200 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $193,403 - $265,812	1,200 New	1,200 $228,000
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $267,259 - $312,924	-1,409 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $258,636 - $305,358	1,409 New	1,409 $276,000

606

152M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.74B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.